2018
DOI: 10.1073/pnas.1805128115
|View full text |Cite
|
Sign up to set email alerts
|

Rational application of macrophage-specific LXR agonists avoids the pitfalls of SREBP-induced lipogenesis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 10 publications
0
7
0
Order By: Relevance
“…We cannot exclude the possibility that the timely differences between the tissue-specific LXR deletion and the LXR agonist injected mice are due to unique pathways. Indeed, previous studies have demonstrated that gene expression response to synthetic LXR agonists could be different from the response to endogenous cholesterol-derived LXR ligands (Magida and Evans, 2018;Muse et al, 2018).…”
Section: Resultsmentioning
confidence: 99%
“…We cannot exclude the possibility that the timely differences between the tissue-specific LXR deletion and the LXR agonist injected mice are due to unique pathways. Indeed, previous studies have demonstrated that gene expression response to synthetic LXR agonists could be different from the response to endogenous cholesterol-derived LXR ligands (Magida and Evans, 2018;Muse et al, 2018).…”
Section: Resultsmentioning
confidence: 99%
“…LXR is a ligand-activated transcription factor, presented as two isoforms, LXRα and LXRβ, which are differentially expressed in different organs [ 127 ]. LXR is able to bind to cholesterol derivatives and intermediate products of its biosynthesis, as well as polyunsaturated fatty acids and some other compounds [ 128 , 129 , 130 , 131 ]. In this case oxysterols act as agonists, while, for example, arachidonic acid, to the contrary, exhibits antagonistic properties [ 129 , 130 , 131 ].…”
Section: Disorders Of Lipid Metabolism In the Development And Progression Of Nafldmentioning
confidence: 99%
“…Only Abcg1 levels were decreased in PirB MΦKO macrophages ( Figure 5E ). As Abcg1 is positively regulated by LXRα/β signaling, we treated the acLDL-exposed PirB flox and PirB MΦKO macrophages with the LXRα/β agonists GW3965 or T0901317 ( Magida and Evans, 2018 ). Notably, both LXRα/β agonists induced Abcg1 upregulation in PirB flox but not PirB MΦKO macrophages ( Figure 5F ).…”
Section: Resultsmentioning
confidence: 99%